IberiaBank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$313K Sell
4,062
-1,726
-30% -$132K 0.04% 178
2020
Q1
$433K Buy
5,788
+1,766
+44% +$122K 0.06% 159
2019
Q4
$261K Sell
4,022
-66
-2% -$4.3K 0.03% 206
2019
Q3
$259K Sell
4,088
-2,209
-35% -$144K 0.03% 201
2019
Q2
$425K Buy
6,297
+2,059
+49% +$135K 0.05% 180
2019
Q1
$276K Sell
4,238
-456
-10% -$30.3K 0.03% 208
2018
Q4
$294K Sell
4,694
-6,365
-58% -$445K 0.04% 208
2018
Q3
$854K Buy
11,059
+1,264
+13% +$95.5K 0.11% 158
2018
Q2
$694K Sell
9,795
-516
-5% -$36.4K 0.12% 154
2018
Q1
$777K Sell
10,311
-11,055
-52% -$879K 0.15% 142
2017
Q4
$1.6M Buy
21,366
+1,151
+6% +$87.4K 0.25% 114
2017
Q3
$1.64M Buy
+20,215
New +$1.55M 0.27% 107
2016
Q2
Sell
-6,421
Closed -$590K 152
2016
Q1
$590K Buy
6,421
+945
+17% +$85.2K 0.28% 75
2015
Q4
$554K Buy
5,476
+472
+9% +$49.1K 0.25% 85
2015
Q3
$491K Buy
5,004
+203
+4% +$22.5K 0.25% 78
2015
Q2
$562K Buy
4,801
+1,032
+27% +$113K 0.25% 75
2015
Q1
$370K Sell
3,769
-891
-19% -$90.5K 0.17% 109
2014
Q4
$439K Buy
4,660
+1,278
+38% +$132K 0.24% 90
2014
Q3
$360K Sell
3,382
-1,538
-31% -$151K 0.2% 96
2014
Q2
$408K Sell
4,920
-1,975
-29% -$154K 0.23% 95
2014
Q1
$489K Sell
6,895
-546
-7% -$42.8K 0.3% 83
2013
Q4
$559K Sell
7,441
-706
-9% -$49.2K 0.37% 73
2013
Q3
$512K Sell
8,147
-1,013
-11% -$60.5K 0.34% 77
2013
Q2
$470K Buy
+9,160
New +$477K 0.35% 80

Other funds holding GILD

IberiaBank's GILD Position: Q2 2020 in Review

IberiaBank reduced its Gilead Sciences (GILD) stake by 30% in Q2 2020, selling an estimated $132K and leaving 4,062 shares worth $313K. The position accounts for 0.04% of the portfolio, ranked #178.

IberiaBank first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.64M in Q3 2017. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • IberiaBank held 4,062 shares of Gilead Sciences worth $313K as of Q2 2020.
  • IberiaBank sold 1,726 Gilead Sciences shares in Q2 2020, an estimated $132K.
  • Gilead Sciences made up 0.04% of IberiaBank's portfolio in Q2 2020, its #178 holding.
  • IberiaBank first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • IberiaBank's Gilead Sciences position peaked at $1.64M in Q3 2017.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.